
BY THE OPTIMIST DAILY EDITORIAL TEAM
A cell therapy built to fight cancer is helping people with stiff person syndrome get back on their feet. In an early trial led by neurologists at Mayo Clinic, patients who had needed family members to help them walk and handle daily tasks regained enough function to return to work, exercise, and hobbies after a single round of CAR-T cell therapy. The results, published in JAMA Neurology, point to a treatment that targets the root of the disease instead of only easing its symptoms.
A rare disease with no cure
What stiff person syndrome does to the body
Stiff person syndrome (SPS) is a rare autoimmune condition in which the immune system attacks the central nervous system. The result can be severe rigidity throughout the body, painful muscle spasms, and frequent falls. Decades of research have produced treatments that can soften symptoms, but none that cure it.
The condition drew global attention in December 2022, when singer Céline Dion revealed her diagnosis. In an Instagram video, she said it affected “every aspect of my daily life,” including her ability to sing.
How CAR-T works against stiff person syndrome
CAR-T therapy is already an established treatment for some blood cancers. Doctors extract a patient’s T cells, a type of immune cell, and engineer them in a lab to seek out and destroy specific targets. For this trial, the cells were redesigned to eliminate the immune cells that drive SPS, using a CD19-targeted therapy called mivocabtagene autoleucel. Each participant received a single treatment, and the study ran across three sites, Mayo Clinic among them.
Dr. Anastasia Zekeridou, a neurologist and researcher at Mayo Clinic in Rochester, Minnesota, said the scale of the response stood out. “What was most striking was the degree of improvement we saw in some patients,” she said. “With existing treatments, we may be able to improve symptoms but we very rarely see patients return to their previous level of function.”
Patients back at work and on the treadmill
Jonathan Walden: hunting and fishing again
Before the trial, Jonathan Walden relied on his family for help with walking and basic daily tasks. He has since returned to his job. “I can go to work every single day. I can do everything I did before. I go hunting; I can go fishing,” he said. “I have not had one episode since receiving treatment.”
Shari St. Germain: seven minutes on a treadmill
Shari St. Germain’s illness progressed from severe leg cramps and trouble walking to rigid muscles and falls. After CAR-T, she said, each day has felt “better and better.” One morning she felt well enough to try the treadmill. “My husband comes running in because I’m crying and he’s like: ‘Are you OK?’ And I’m like: ‘I just walked for seven minutes on the treadmill,’” she said.
Next questions for CAR-T in neurology
Will the improvements last?
The researchers are clear that this is early evidence from a small, nonrandomized trial, and that larger studies are needed. “These early results are very encouraging and the key question now is whether those improvements will be sustained over time,” Zekeridou said.
Beyond blood cancer
Dr. Sean Pittock, who chairs the department of neurology at Mayo Clinic, sees a wider opening. “CAR-T therapy has already transformed the treatment of some cancers, and we are now beginning to see its potential in autoimmune neurologic diseases,” he said, adding that the results offer hope for other immune-mediated neurologic conditions with few effective options. Yasmin Sheikh, head of policy and public affairs at the UK blood cancer charity Anthony Nolan, which was not involved in the trial, called the research “an exciting development” and more evidence that CAR-T could reach well beyond blood cancer. If the gains hold in larger trials, people with stiff person syndrome could have something they have never had before: a treatment aimed at giving them back the lives the disease took, not just making those lives easier to manage.
Did this solution stand out? Share it with a friend or support our mission by becoming an Emissary.
The post CAR-T therapy helps stiff person syndrome patients walk and work again first appeared on The Optimist Daily: Making Solutions the News.
BY THE OPTIMIST DAILY EDITORIAL TEAM A cell therapy built to fight cancer is helping people with stiff person syndrome get back on their feet. In an early trial led by neurologists at Mayo Clinic, patients who had needed family members to help them walk and handle daily tasks regained enough function to return to
The post CAR-T therapy helps stiff person syndrome patients walk and work again first appeared on The Optimist Daily: Making Solutions the News.